Neuroreader™ is an advanced piece of software that analyzes data from a patient's structural MRI scan, measures 45 different brain structures (two-dozen more than any current competing software), and compares them to an FDA-cleared normative database of scans from a diverse population of healthy individuals.

In this video, David Merrill, MD, PhD describes how a physician might use the volumetric information provided by the Neuroreader™ software to help target treatments to specific regions of the brain. Dr. Merrill also highlights a hypothetical situation where a patient is suspected to have Alzheimer's disease, but the MRI data, as read through the Neuroreader™ software, indicates a normal hippocampus volume and reduced frontal lobe volumes, which could indicate the need to screen for depression.